Online Platform for Neurofibromatosis
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help people with Neurofibromatosis 1 (NF1) better understand their condition and care options. Researchers seek to evaluate the effectiveness and user-friendliness of two approaches: educational videos about NF1 and support from a peer navigator, who guides and advises others with the same condition. Participants will also receive personalized care letters for themselves and their doctors. The trial seeks adults in the U.S. with NF1, low health literacy, and an upcoming wellness visit with their primary care provider.
As an unphased trial, this study offers participants a unique opportunity to gain valuable insights and support in managing their condition.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on educational support rather than medication changes.
What prior data suggests that these approaches are safe for NF1 patients?
A previous study on the PEERS intervention, similar to the Peer Navigator program, showed promise in helping teenagers with Neurofibromatosis Type 1 (NF1) improve their social skills. This suggests that the Peer Navigator might also be helpful and safe for adults. Reports have not indicated any serious side effects from these peer support programs.
Regarding the NF1 Educational Videos, direct safety data is unavailable. However, educational videos are generally considered safe as they provide information rather than medical treatment. These videos aim to help people understand their condition better, potentially improving how they manage their health.
Overall, both interventions are non-invasive and have not shown any safety concerns in similar contexts. This study focuses on educating and supporting people with NF1 rather than testing a new drug or medical procedure.12345Why are researchers excited about this trial?
Researchers are excited about the Online Platform for Neurofibromatosis because it introduces innovative methods like NF1 Educational Videos and a Peer Navigator to support individuals with NF1. Unlike traditional treatments that focus primarily on medical interventions, this platform emphasizes education and peer support, helping patients understand their condition better and connect with others facing similar challenges. These approaches can empower patients by providing easily accessible information and a community network, potentially enhancing their overall quality of life and self-management skills.
What evidence suggests that this trial's treatments could be effective for improving understanding of NF1 symptoms and care?
This trial will compare different methods to enhance understanding of NF1 care. Research has shown that educational videos, one method tested in this trial, can simplify complex health information. Specifically, one study found that videos in a telehealth program improved social skills in teenagers with NF1, suggesting that videos might also enhance adults' understanding of NF1 care.
For the peer navigator approach, another method tested in this trial, earlier studies show it can assist people with NF1 in understanding and managing their condition. Peer navigators, trained guides who offer support, have successfully taught social skills to teenagers with NF1. This success indicates they could also help adults manage their healthcare more effectively. Both methods aim to make NF1 care information more accessible for those with limited health knowledge.56789Who Is on the Research Team?
Vanessa Merker, PhD
Principal Investigator
Massachusetts General Hospital
Are You a Good Fit for This Trial?
This trial is for adults in the U.S. with Neurofibromatosis 1 (NF1) who have low health literacy and an upcoming annual wellness visit with their primary care provider. Eligibility will be determined through a prescreening survey.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete baseline survey assessments online before their PCP visit
Intervention
Participants are randomized to receive either NF1 educational videos or a call with an NF1 peer navigator, along with personalized NF1 care letters
Follow-up
Participants complete an online follow-up survey and a small subsample participates in a virtual qualitative interview
What Are the Treatments Tested in This Trial?
Interventions
- Letters about NF1 Care
- NF1 Educational Videos
- Peer Navigator
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor
United States Department of Defense
Collaborator